Epstein-barr virus, the immune system, and associated diseases

Area of Science:

• Virology
• Immunology
• Oncology

Background:

• The human immune system combats pathogens, but viruses like Epstein-Barr virus (EBV) can infect immune cells, disrupting homeostasis.
• EBV, discovered over 45 years ago, transforms B cells in vitro, suggesting oncogenic potential, yet its role in specific malignancies remains unclear.
• While EBV's role in post-transplant lymphoproliferative disease is understood, the reasons for its association with other cancers in a small subset of individuals are ambiguous.

Purpose of the Study:

• To review recent advances on the complex interplay between Epstein-Barr virus and the host immune system.
• To explore EBV's broader impact on immune regulation beyond B cell infection, including NKT cell development.
• To stimulate further research into EBV-associated diseases, particularly autoimmune conditions.

Main Methods:

• This article is a review, synthesizing recent findings rather than presenting new experimental data.
• It focuses on literature linking EBV infection, immune system modulation, and disease development.
• Key areas explored include EBV's oncogenic potential and its influence on immune homeostasis.

Main Results:

• EBV infection can modulate host immune homeostasis by infecting immune cells.
• EBV's oncogenic potential is suggested by its ability to transform B cells.
• Recent studies indicate EBV impacts the immune system more broadly, influencing regulatory NKT subsets.

Conclusions:

• The precise mechanisms by which EBV contributes to specific malignancies, beyond known associations, require further investigation.
• EBV may act in conjunction with environmental and genetic factors to promote EBV-associated neoplastic diseases.
• Understanding EBV's comprehensive effects on the immune system is crucial for future research, especially concerning autoimmune diseases.